General comments:
The use of the expression "potential patients and surrogates" is misleading. It is a population survey where participants are asked to imagine that they are personally concerned ("patient perspective") or a family member is concerned ("surrogate perspective"). There are not 2 different groups. Moreover the "surrogate perspective" explores participants' opinion of how a decision should be made for a family member. Participants are not instructed to think of themselves as a surrogate decision maker and then to decide which approach suits them best. So the point of view adopted may have varied greatly among participants and blur a potential difference between the "patient" group and the "surrogate" group. The phrasing of the statement was rather vague : participants may have very different ideas of what « advanced Alzheimer's disease » or « coma after an accident » means, of what life-sustaining medical treatments are. Some options tested are rather artificial and not readily applicable in practice (family voting, statistical prediction rule) or no longer considered good practice (the physician decides all by himself). It makes the findings less informative. On the other hand, the authors did not test a shared decision making approach where the physician interacts with and supports the surrogates. This kind of approach is often used in clinical practice, for example in the context of treatment decisions in the intensive care unit, decisions which often have vital consequences for the patient. They did not either test the approach they describe in the introduction, namely the use of statistical prediction rule as an aid in shared decision making.
Specific comments

Introduction:
The introduction could be shorter and should focus more on the context of the study. What do the German and the Swiss legislations say about surrogate decision making? What are the similarities and differences between them? Procedural preferences may differ according to the clinical situation or the decision to be made. The authors' argument according to which "Given that the differences in accuracy between the currently available approaches to making surrogate decisions are negligible, 9-11 it is all the more important to have a solid empirical assessment of people's procedural preferences" is not very strong. Interest for knowing procedural preferences is rather triggered by 1) the interest of increasing prediction accuracy by favoring the appropriate approach 2) the fact that there will always be some uncertainty about the accuracy of the decision and that it can be somewhat counterbalanced by an adequate decision making process.
Methods :
The question analysed in the manuscript seems to be part of a larger questionnaire. If so, please give more information about the questionnaire and its purpose. Participants as young as 14 years old were included : explain the choice of this age limit. How did the authors ensure that these participants (minors) gave informed consent and understood the clinical and legal context (validity of answer) ? Was the study approved by an ethical committee for research? Describe the compensation received by the participants. What was the method of randomization of participants into the patient role or the "surrogate" role? How were the predictors chosen ? It is not clear why to be employed would change preferences of approach. Some interesting factors were not tested, for example a previous experience with surrogate decision making, personal experience with a loved one's terminal illness or with Alzheimer's disease. Please comment on that. The participants were given the option of "an individual person determined according to a legal hierarchy ». Although technically correct, this phrasing leaves out an important point of the Swiss legislation. The Swiss law specifies that the person must have close ties with the patient, emphasizing that personal relationship matters more than blood ties. How do the authors account for that in the interpretation of the results?
Results:
It would be interesting to know the response rate and to indicate in table 1. the repartition by age group Were there differences between the participants with the patient's perspective and the participants with the surrogate's perspective ? Table 2 : for a general medical audience, table 2 is difficult to read, it is difficult to understand what the numbers stand for and how to  interpret them   Discussion: The main results are summarized but there is no discussion, contextualization or interpretation of the findings. The association of factors with preferred approaches (e.g., employed respondents were less in favour of a statistical prediction rule) needs discussing. The authors did not comment about the limitations of the study. The opinion of the general population about surrogate decision making is certainly interesting, but the authors suggest it is more relevant than patients' and surrogates' opinion. The reasons they give for that are not convincing. Much research on surrogate decision making has been conducted with patients and surrogates, and some of it is found in the references (Vig EK, Shalowitz DI). Patients and surrogates are directly concerned by the topic and can rely on their experience rather than try to imagine hypothetical scenarios. Most situations of surrogate decision making do not concern individuals becoming unexpectedly incapacitated and the number of such situations will increase with the ageing of the population. The authors are very affirmative about the implications of the results for clinicians and policy. These opinions should be reviewed in light of the limitations of the study. The same is true for the conclusions. 
REVIEWER
GENERAL COMMENTS
The authors present the results of their population-based survey study in Germany in Switzerland. In this survey study in approximately 2000 participants, hypothetical scenarios were provided and participants were asked to provide their preference for 6 different decision-making options if they were either the affected and incapacitated patient or the surrogate-decision maker of the affected patient. The authors report that there was variability across the six options to making surrogate decisions. There was parallel alignment of preferred decision making as patients or surrogates. The preferred approaches were patient-designated surrogate and collective family decision with group discussion, while the leastpreferred approaches were using only a statistical prediction rule and delegating the decision solely to the physician. The authors also report that only 36% of the respondents already have a surrogate decision-maker designated in real life. The authors report on an exploratory regression analyses and report some adjusted predictors of preferred decision-making.
Overall this study explores a very important topic, and employs an accepted population survey approach to capture a large diverse population between the two countries Germany and Switzerland.
There are several areas which require clarification, more details, or re-writing to improve the manuscript, correct errors and make it easier to follow for the reader: The authors should pay close attention to their use of "Shared decision making" and make sure that it aligns with the actual meaning of the term throughout their entire manuscript.
6. The authors equate a "decision aid" with a statistical prediction rule. This is incorrect. A decision aid contains far more components than just that, as has been outlined by the International Patient Decision Aid Standards (IPDAS) criteria. Please refer to these links: https://decisionaid.ohri.ca/ and http://ipdas.ohri.ca/.
7. Why were respondents aged 14-18 included? in reality, surrogate decision makers have to be 18, even in Germany, to be allowed to act as surrogate decision makers. Please also note the % of respondents in this age group. I'm not clear on the value of including this age group.
8. How was the survey developed, tested and what kind of cognitive testing was done before employing it?
9. How was health literacy measured? if it wasn't, please justify. Also justify how you adjusted for health literacy.
10. The exploratory regression analysis is quite difficult to follow.
What exactly was done? the results seem to be reporting selectively. Could you also report on subgroup analyses, such as was there a difference between different age groups in terms of preferences? Also by education level and household income? Rural vs. urban respondents?
11. Table 2 is very difficult to read and not of interest to the general reader, unless a survey statistician. Instead, subgroup analyses as requested above would be a lot more interesting. Table 2 may be better off as supplemental data.
12. The statistical approach description is very technical and at the level of a survey statistician. The authors should simply it yet include enough description for a clinician or non-survey researcher to be able to follow what was done and why.
13. The abstract contains jargon that is not explained, such as "active choice". It is not clear what that is. Also, similarly as above, the term "shared decision making" is used incorrectly in the abstract.
14. It is unusual to list strengths and weaknesses before the discussion of the findings in the context of other research. The authors may want to change the order of their sub-sections in the discussion.
15. The authors should highlight in their title and abstract that this study and its findings are limited to two countries only -Germany and Switzerland. they should make sure to emphasize that they cannot generalize their findings to other European or non-European countries.
VERSION 1 -AUTHOR RESPONSE
Responses to reviewer comments Reviewer: 1 Reviewer Name: M. Escher Institution and Country: Hôpitaux Universitaires de Genève, Switzerland Please state any competing interests or state 'None declared': none declared This is a population survey including a large representative sample in Germany and in the German and the French speaking parts of Switzerland. Surrogate decision making is an important topic, especially in the light of an increasing elderly population, as the authors rightly point out. However the argumentation for asking the general population about different decision making procedures is not compelling. The study is based on a single general statement, requesting the participants to imagine themselves in a hypothetical extreme situation (life and death decision). The findings are expected and do not add much to the current knowledge. We disagree with this general evaluation of our empirical contribution, because anyone (!) in the population can become an incapacitated patient (this includes people of any age, and can occur completely unexpectedly), and many persons may thus sooner or later become surrogates themselves. Hence it is extremely important to know people's procedural preferences regarding these difficult situations. Let us also point out here that BMJ Open's editorial policy clearly states that it is up to the reader to make such judgments of importance and breadth of appeal. General comments: The use of the expression "potential patients and surrogates" is misleading. It is a population survey where participants are asked to imagine that they are personally concerned ("patient perspective") or a family member is concerned ("surrogate perspective"). There are not 2 different groups. We were surprised by this general comment, because already in the second sentence of the abstract we have explicitly stated that "Respondents were randomly assigned to either the perspective of an incapacitated patient or that of a potential surrogate for an incapacitated family member". Thus, we cannot see how this creates the impression of two different (pre-existing) groups. Of course, everyone in the population is a "potential patient" and a "potential surrogate", and the two perspectives are accordingly reflected in the two experimental groups. Nevertheless, we have now tried to make this point even more explicit throughout the entire manuscript. Moreover the "surrogate perspective" explores participants' opinion of how a decision should be made for a family member. Participants are not instructed to think of themselves as a surrogate decision maker and then to decide which approach suits them best. So the point of view adopted may have varied greatly among participants and blur a potential difference between the "patient" group and the "surrogate" group. For the following reason, we disagree with the suggested (alternative) methodology: Priming an apriori default (i.e., to consider oneself a surrogate) may lead to systematic reporting biases due to anchoring effects. This is exactly why we presented the different approaches in a randomized order. Please note that at least three of the different approaches included the participant in the surrogate perspective as a potential surrogate him-/herself. We agree, but given the breadth of circumstances (in terms of diseases, accidents, as well as person characteristics such as age) that can result in a person becoming an incapacitated patient, we aimed to be as inclusive as possible. Yet, because of the large sample the true signal in participants' preferences will emerge nevertheless, despite some degree of noise that is inevitable with such a relatively inclusive survey question. Some options tested are rather artificial and not readily applicable in practice (family voting, statistical prediction rule) or no longer considered good practice (the physician decides all by himself). It makes the findings less informative. On the other hand, the authors did not test a shared decision making approach where the physician interacts with and supports the surrogates. This kind of approach is often used in clinical practice, for example in the context of treatment decisions in the intensive care unit, decisions which often have vital consequences for the patient. They did not either test the approach they describe in the introduction, namely the use of statistical prediction rule as an aid in shared decision making. Our selection of surrogate decision-making approaches has been based on past research on this topic, in particular whether prior studies have examined the predictive accuracy of particular approaches. There are numerous examples for such studies. We agree that it would be interesting to test combinations of the presented approaches in the future. However, we strongly disagree with the reviewer's evaluation that the lack of such combinations in the present study does make the present findings "less informative" (also, as we understand from BMJ Open's editorial policies, reviewers may not make any judgments regarding importance or breadth of appeal, as readers will be able to make these judgements themselves.) Specific comments Introduction:
The introduction could be shorter and should focus more on the context of the study. What do the German and the Swiss legislations say about surrogate decision making? What are the similarities and differences between them? We appreciate this comment and have implemented them as suggested. Procedural preferences may differ according to the clinical situation or the decision to be made. The authors' argument according to which "Given that the differences in accuracy between the currently available approaches to making surrogate decisions are negligible, 9-11 it is all the more important to have a solid empirical assessment of people's procedural preferences" is not very strong. Interest for knowing procedural preferences is rather triggered by 1) the interest of increasing prediction accuracy by favoring the appropriate approach 2) the fact that there will always be some uncertainty about the accuracy of the decision and that it can be somewhat counterbalanced by an adequate decision making process. Of course, there will be differences in accuracy across different medical scenarios / situations (e.g., see Frey et al, 2014, Medical Decision Making) . However, and as we have reviewed extensively, many studies have actually found that there is no single approach that clearly outperforms other approaches in terms of predictive accuracy. Hence, the second criterion "procedural preference", which cannot be influenced by an approach's accuracy as just highlighted, becomes even more important. Again, we would like to remind that according to BMJ Open's editorial policies, the reader will eventually make the judgment whether he/she finds the criterion of "procedural preferences" important him-/herself.
Methods :
The question analysed in the manuscript seems to be part of a larger questionnaire. If so, please give more information about the questionnaire and its purpose. We added further details to the manuscript. Participants as young as 14 years old were included : explain the choice of this age limit. How did the authors ensure that these participants (minors) gave informed consent and understood the clinical and legal context (validity of answer) ? Was the study approved by an ethical committee for research? Describe the compensation received by the participants. What was the method of randomization of participants into the patient role or the "surrogate" role? We added the requested details to the manuscript. Regarding the age range: We believe that it is tremendously important to learn about procedural preferences across all age groups. This is particularly true if the underage person is the incapacitated patient, but possibly also from the perspectives of surrogates: Whereas legal requirements may differ from country to country, a teenager's opinion and preferences likely also have an important influence in a family discussion on a surrogate decision. The age of 14 was the lower limit of participants whom the employed survey company typically recruits in this type of studies, and we have thus decided to set this as the lower limit. How were the predictors chosen ? It is not clear why to be employed would change preferences of approach. Some interesting factors were not tested, for example a previous experience with surrogate decision making, personal experience with a loved one's terminal illness or with Alzheimer's disease. Please comment on that. We agree that further questions would have been interesting. Yet, in the interest of time we were restricted to the assessment of some basic socio-demographic variables as predictors of procedural preferences. We have included all available potential predictors in the analyses. The participants were given the option of "an individual person determined according to a legal hierarchy ». Although technically correct, this phrasing leaves out an important point of the Swiss legislation. The Swiss law specifies that the person must have close ties with the patient, emphasizing that personal relationship matters more than blood ties. How do the authors account for that in the interpretation of the results?
The hierarchy that we implemented in this item is closely aligned to the Swiss legal system. However, as this reviewer points out, to make it a perfect match one would need to add the following to each level of the hierarchy "... if they regularly and personally provide the person lacking capacity of judgement with support;". In the interest of making the approaches as comparable as possible and to test them in their "purest form", we did not include such qualifiers. Otherwise, we would also have needed to add specific qualifiers to the other approaches (e.g., "a physician who has been treating the patient for X years"; "a personally designated surrogate, provided that this surrogate has been in contact with the patient for the last Y years", etc.
). Yet, this is an important point that we have now added to the discussion.
Results:
It would be interesting to know the response rate and to indicate in table 1. the repartition by age group Were there differences between the participants with the patient's perspective and the participants with the surrogate's perspective ? Unfortunately, the exact response rate is not available for this survey. However, according to the survey company the general response rate is about ~30%. This does not seem to be high, yet constitutes a normal level in similar population surveys. Moreover, given our randomized design, we can exclude the possibility that there were different response rates between the patient and surrogate perspectives. Table 2 : for a general medical audience, table 2 is difficult to read, it is difficult to understand what the numbers stand for and how to interpret them Even though these are state-of-the art Bayesian beta regressions, the coefficients can be interpreted exactly as "normal" regression coefficients thanks to our back-transformation. We have now added this information in the table note. Discussion:
The main results are summarized but there is no discussion, contextualization or interpretation of the findings. The association of factors with preferred approaches (e.g., employed respondents were less in favour of a statistical prediction rule) needs discussing. The authors did not comment about the limitations of the study. Under the section "Strengths and limitations" we had already systematically discussed limitations of this study. But we appreciate the comment that we should discuss some of the findings in more depth and now do so. The opinion of the general population about surrogate decision making is certainly interesting, but the authors suggest it is more relevant than patients' and surrogates' opinion. The reasons they give for that are not convincing. Much research on surrogate decision making has been conducted with patients and surrogates, and some of it is found in the references (Vig EK, Shalowitz DI). Patients and surrogates are directly concerned by the topic and can rely on their experience rather than try to imagine hypothetical scenarios. Most situations of surrogate decision making do not concern individuals becoming unexpectedly incapacitated and the number of such situations will increase with the ageing of the population. Again, we believe that according to BMJ Open's editorial policy, the reader should ultimately make judgments regarding the importance and breadth of appeal of this empirical contribution him-/herself. Yet, we had specifically discussed this point under potential limitations (see previous comment). Let us just briefly point out here that research on surrogate decision making with actual patients does not exist per definition (because these patients are incapacitated and cannot report their preferences), and research involving actual surrogates is an extreme exception (e.g., Vig et al., 2007) . The vast majority of other research on surrogate decision making is based on hypothetical scenarios, which is considered an accepted and informative method in this field. Also, we are convinced that we need a much better understanding of potential surrogates' (and potenial patients'!) preferences across the entire agerange. Take, for example, the famous case of Terri Schiavo, who had suffered cardiac arrest at the age of 27, and consequently become incapacitated. Her potential surrogates (i.e., her husband and her parents) faced tremendously difficult decisions out of the sudden -a fate that potential surrogates of both young and old people can face at any time!
The authors are very affirmative about the implications of the results for clinicians and policy. These opinions should be reviewed in light of the limitations of the study. The same is true for the conclusions. We appreciate this comment and have now revised these sections. Reviewer: 2 Reviewer Name: Susanne Muehlschlegel, MD, MPH Institution and Country: Depts. of Neurology, Anesthesia/Critical Care & Surgery, University of Massachusetts Medical School, Worcester, MA, USA Please state any competing interests or state 'None declared': none declared Please leave your comments for the authors below The authors present the results of their population-based survey study in Germany in Switzerland. In this survey study in approximately 2000 participants, hypothetical scenarios were provided and participants were asked to provide their preference for 6 different decision-making options if they were either the affected and incapacitated patient or the surrogate-decision maker of the affected patient. The authors report that there was variability across the six options to making surrogate decisions. There was parallel alignment of preferred decision making as patients or surrogates. The preferred approaches were patientdesignated surrogate and collective family decision with group discussion, while the least-preferred approaches were using only a statistical prediction rule and delegating the decision solely to the physician. The authors also report that only 36% of the respondents already have a surrogate decision-maker designated in real life. The authors report on an exploratory regression analyses and report some adjusted predictors of preferred decision-making. Overall this study explores a very important topic, and employs an accepted population survey approach to capture a large diverse population between the two countries Germany and Switzerland. There are several areas which require clarification, more details, or re-writing to improve the manuscript, correct errors and make it easier to follow for the reader: 1. The authors seem to employ an incorrect, or at least not a universal definition, of surrogate decision-making. They state that "Surrogate decisions are decisions made on behalf of patients who are no longer able to express their treatment preferences and who have not provided a detailed advance directive (i.e., a "living will")." However, many countries, including the U.S. We have now clarified this point. 1. The introduction is overall too long in relation to the remainder of the manuscript. Particularly there is too much detail on accuracy of decision making, while the manuscript and study itself does not involve accuracy, but preference of decision-making. This should be substantially shortened. Of course, one might argue that accuracy should have the first priority when evaluating different approaches. Thus it is important to highlight that none of the current approaches clearly stands out in terms of accuracy. But we appreciate this comment and have now shortened this part accordingly. 1. The manuscript is missing the objective and hypothesis. Please state explicitly. We had stated the objective clearly in the abstract (see "objective"). As this is the first study reporting procedural preferences in representative population samples, we did not aim to test a particular prediction. However, we have now added a cautious prediction (based on a first but much smaller study with a similar goal) in the introduction. 1. The authors seem to mis-use the term "shared decision making", which is a well-defined process of decision making. It does not refer to sharing decision making among different surrogates or family members to lessen the burden on them, as implied by the authors. Shared decision making is "a process in which clinicians and patients work together to make decisions and select tests, treatments and care plans based on clinical evidence that balances risks and expected outcomes with patient preferences and values." (Source: https://www.healthit.gov). The Institute of Medicine defines it as "care that is respectful of and responsive to individual patient preferences, needs, and values" and that ensures "that patient values guide all clinical decisions." SDM includes the importance of clinicians and patients working together to produce the best outcomes possible. [Barry MJ, EdgmanLevitan S. Shared decision making--pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780-1]. The authors should pay close attention to their use of "Shared decision making" and make sure that it aligns with the actual meaning of the term throughout their entire manuscript. We are aware of the typical use of "shared decision making", and our use of "shared surrogate decision making" was meant to be an extension of the traditional use. Of course, "shared decision making" is an approach employed and studied beyond the discipline of medicine (e.g., in fairness research). Yet, to avoid potential misunderstandings, we have now clarified this point throughout the manuscript. 1. The authors equate a "decision aid" with a statistical prediction rule. This is incorrect. A decision aid contains far more components than just that, as has been outlined by the International Patient Decision Aid Standards (IPDAS) criteria. Please refer to these links: https://decisionaid.ohri.ca/ and http://ipdas.ohri.ca/. We actually disagree with this comment, as we did not mean and in fact did not equate "decision aid" with "statistical prediction rule". Rather, we referred to the "statistical decision rule" as an example of a decision aid (therefore we used "e.g." and "such as"). To avoid any misunderstandings, we are now even more explicit about this. 1. Why were respondents aged 14-18 included? in reality, surrogate decision makers have to be 18, even in Germany, to be allowed to act as surrogate decision makers. Please also note the % of respondents in this age group. I'm not clear on the value of including this age group.
We believe that it is tremendously important to learn about procedural preferences across all age groups, including situations in which patients and surrogates are underage. From the perspectives of surrogates, legal requirements may differ from country to country, yet a teenager's opinion and preference may also have an important influence in a family discussion. The requested details have been added. 1. How was the survey developed, tested and what kind of cognitive testing was done before employing it? The survey was largely based on a previous empirical study (Frey et al., 2014) , and has been internally tested for feasibility by the professional survey company. Consequently, no specific cognitive testing has been done. 1. How was health literacy measured? if it wasn't, please justify. Also justify how you adjusted for health literacy. We agree that it would have been another interesting variable to be collected (which we could not in the interest of time). However, we would see this variable as an interesting additional predictor of participants' preferences rather than something "to be controlled for", as we aimed to assess participants' absolute preferences as closely as possible. 1. The exploratory regression analysis is quite difficult to follow. What exactly was done? the results seem to be reporting selectively. Could you also report on subgroup analyses, such as was there a difference between different age groups in terms of preferences? Also by education level and household income? Rural vs. urban respondents?
We wondered where / how Reviewer 2 got the impression of selected reporting? The desired predictors are fully reported in Table 2 (please also note that in the interest of open science and reproducibility, the entire dataset is available on http://osf.io, as indicated in the method section). We chose to report age as a continuous predictor, which of course retains more information than breaking this variable into ordinal groups (and it would be a shame not to use this information, given the large and representative population samples). We have now revised out explanation of the regression analyses to make it somewhat simpler. 1. Table 2 is very difficult to read and not of interest to the general reader, unless a survey statistician. Instead, subgroup analyses as requested above would be a lot more interesting. The authors should simply it yet include enough description for a clinician or non-survey researcher to be able to follow what was done and why. We believe that with our revised description, the readers of BMJ Open should be able to fully understand the details of our analyses now. 1. The abstract contains jargon that is not explained, such as "active choice". It is not clear what that is. Also, similarly as above, the term "shared decision making" is used incorrectly in the abstract. Thanks for pointing out this issue, we have now revised this.
1. It is unusual to list strengths and weaknesses before the discussion of the findings in the context of other research. The authors may want to change the order of their sub-sections in the discussion. We have revised this section now. 1. The authors should highlight in their title and abstract that this study and its findings are limited to two countries only -Germany and Switzerland. they should make sure to emphasize that they cannot generalize their findings to other European or non-European countries.
In the abstract, we specifically state "Setting: Germany and German-and French-speaking parts of Switzerland." and we thus think that it is self-evident (as in every non-global study) that country effects might be a limitation to some extent. Yet we believe that our findings would at least generalize to most Western countries (see discussion section).
There might be differences in other cultures, which would be interesting to study in the future.
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